Obstructive sleep apnea is common in patients with interstitial lung disease
- 880 Downloads
The incidence of obstructive sleep apnea (OSA) in interstitial lung disease (ILD) has been reported at different frequencies in several studies. The aims of our study were to evaluate the frequency of OSA in ILD and to analyze the relationship between polysomnography (PSG) findings and pulmonary function, disease severity, parenchymal involvement, and Epworth Sleepiness Scale (ESS) scores.
ILD patients with parenchymal involvement were evaluated. The disease severity was assessed using an index consisting of body mass index (BMI), carbon monoxide diffusion capacity, the Modified Medical Research Council dyspnea scale, and the 6-min walking distance. All of the patients had lung function, chest X-ray, PSG, ESS scoring, and an upper airway examination. Patients with a BMI ≥ 30 or significant upper airway pathologies were excluded.
Of 62 patients, 50 patients comprised the study group (14 male, 36 female; mean age 54 ± 12.35 years, mean BMI 25.9 ± 3.44 kg/m2) with diagnoses of idiopathic pulmonary fibrosis (IPF; n = 17), stage II–III sarcoidosis (n = 15), or scleroderma (n = 18). The frequency of OSA was 68 %. The mean apnea–hypopnea index (AHI) was 11.4 ± 12.5. OSA was more common in IPF patients (p = 0.009). The frequency of rapid eye movement-related sleep apnea was 52.9 %. The frequency of OSA was higher in patients with a disease severity index ≥3 (p = 0.04). The oxygen desaturation index and the AHI were higher in patients with diffuse radiological involvement (p = 0.007 and p = 0.043, respectively).
OSA is common in ILD. PSG or at minimum nocturnal oximetry should be performed, particularly in patients with functionally and radiologically severe disease.
KeywordsIdiopathic pulmonary fibrosis Interstitial lung disease Obstructive sleep apnea Scleroderma Sarcoidosis
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.American Academy of Sleep Medicine (2005) International classification of sleep disorders, 2nd ed: diagnostic and coding manual. American Academy of Sleep Medicine, WestchesterGoogle Scholar
- 3.Rasche K, Orth M (2009) Sleep and breathing in idiopathic pulmonary fibrosis. J Physiol Pharmacol 5:13–14Google Scholar
- 4.Pitsiou G, Bagalas V, Boutou A, Stanopoulos I, Argyropoulou-Pataka P (2013) Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia? Sleep Breath. pmid:22562264/doi: 10.1007/s11325-012-0716-0.
- 16.Khosla T, Lowe FR (1967) Indices of obesity derived from body weight and height. Br Soc Med 21:122–128Google Scholar
- 19.Polysomnography Taske Force, American Sleep Disorders Association Standards of Practice Committee (1997) Practice parameters for the indications for polysomnography and related procedures. Sleep 20:406–422Google Scholar
- 20.Iber C, Ancoli-Israel S, Stuart Quan M (2007) The American Academy of Sleep Medicine manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. American Academy of Sleep Medicine, WestchesterGoogle Scholar
- 32.Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D (2010) How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 14:387–390PubMedCrossRefGoogle Scholar